Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Total Liabilities (2021 - 2025)

Historic Total Liabilities for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $3.3 million.

  • Coeptis Therapeutics Holdings' Total Liabilities fell 1783.54% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 1783.54%. This contributed to the annual value of $5.0 million for FY2024, which is 3418.33% up from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Total Liabilities is $3.3 million, which was down 1783.54% from $5.1 million recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Total Liabilities peaked at $10.4 million during Q2 2021, and registered a low of $310060.0 during Q2 2024.
  • Moreover, its 5-year median value for Total Liabilities was $4.6 million (2022), whereas its average is $4.8 million.
  • As far as peak fluctuations go, Coeptis Therapeutics Holdings' Total Liabilities plummeted by 9403.19% in 2024, and later surged by 154850.32% in 2025.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Total Liabilities stood at $4.4 million in 2021, then dropped by 21.58% to $3.5 million in 2022, then increased by 8.51% to $3.8 million in 2023, then surged by 34.18% to $5.0 million in 2024, then tumbled by 35.24% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $5.1 million for Q2 2025, and $6.0 million during Q1 2025.